News & Articles

The EBV panel can be used to rule out other acute infections, such as missed HIV infections

Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence

Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges

This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency

Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR

Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

A response to the unprecedented global demand for key scientific resources

By consolidating up to four analytical units on a single platform, testing efficiency in high-volume labs is increased

Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test

Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall

The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase